Načítá se...
Granulopoiesis‐stimulating factors to prevent adverse effects in the treatment of malignant lymphoma
BACKGROUND: Granulopoiesis‐stimulating factors, such as granulocyte‐colony‐stimulating factor (G‐CSF) and granulocyte‐macrophage‐colony‐stimulating factor (GM‐CSF), are being used to prevent febrile neutropenia and infection in patients undergoing treatment for malignant lymphoma. The question of wh...
Uloženo v:
| Vydáno v: | Cochrane Database Syst Rev |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
John Wiley & Sons, Ltd
2008
|
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7144686/ https://ncbi.nlm.nih.gov/pubmed/18843642 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD003189.pub4 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|